Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brian Wilson

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Diabetes|November 12, 2009
Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian rouletteJohn P Driver, Felix Scheuplein, Yi-Guang Chen, et al.
Clinical Immunology (Orlando, Fla.)|February 29, 2008
Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotypeCarlos J Montoya, Juan C Cataño, Zoraida Ramirez, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulationMarisa L Blauvelt, Maryam Khalili, Weonjoo Jaung, et al.
AIDS Research and Human Retroviruses|August 7, 2007
Delayed reconstitution of CD4+ iNKT cells after effective HIV type 1 therapyOtto O Yang, S Brian Wilson, Lance E Hultin, et al.
Virology|May 27, 2005
Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complexSungyoo Cho, Kenneth S Knox, Lisa M Kohli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cellsBalgansuren Gansuvd, William J Hubbard, Anne Hutchings, et al.
The Journal of Experimental Medicine|May 5, 2004
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2Leonid S Metelitsa, Hong-Wei Wu, Hong Wang, et al.
Immunology|July 31, 2007
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11Carlos J Montoya, David Pollard, Jeffrey Martinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
CD1d and invariant NKT cells at the human maternal-fetal interfaceJonathan E Boyson, Basya Rybalov, Louise A Koopman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cellsCarlos J Montoya, Hyun-Bae Jie, Lena Al-Harthi, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Diabetes|November 12, 2009
Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian rouletteJohn P Driver, Felix Scheuplein, Yi-Guang Chen, et al.
Clinical Immunology (Orlando, Fla.)|February 29, 2008
Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotypeCarlos J Montoya, Juan C Cataño, Zoraida Ramirez, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulationMarisa L Blauvelt, Maryam Khalili, Weonjoo Jaung, et al.
AIDS Research and Human Retroviruses|August 7, 2007
Delayed reconstitution of CD4+ iNKT cells after effective HIV type 1 therapyOtto O Yang, S Brian Wilson, Lance E Hultin, et al.
Virology|May 27, 2005
Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complexSungyoo Cho, Kenneth S Knox, Lisa M Kohli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cellsBalgansuren Gansuvd, William J Hubbard, Anne Hutchings, et al.
The Journal of Experimental Medicine|May 5, 2004
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2Leonid S Metelitsa, Hong-Wei Wu, Hong Wang, et al.
Immunology|July 31, 2007
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11Carlos J Montoya, David Pollard, Jeffrey Martinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
CD1d and invariant NKT cells at the human maternal-fetal interfaceJonathan E Boyson, Basya Rybalov, Louise A Koopman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cellsCarlos J Montoya, Hyun-Bae Jie, Lena Al-Harthi, et al.
Pageof 4